论文部分内容阅读
一、问题的提出:2005年张慧琴(化名)在接受深圳富华医疗美容医院“奥美定注射”丰颞“手术后,面部痛苦不堪,其后虽经两次手术抽取仍然未能解除病痛,于是便投书国家信访局和各级食品药品监督局反映情况,同时她还接受了中央电视台”生活3·15“栏目的采访,在”搜狐“网上撰文披露”奥美定“产品存在不良反应。,吉林富华公司以张慧琴寄给国家信访局的投诉信为证据将张慧琴告上法庭。9月20号长春市南关区法院对吉林富华公司诉张慧琴名誉权纠纷一案(下文简称”张案“)作出了被告败诉的一审判决。在轰动全国的”奥美定“事件中,张慧琴被认为是推动事件发展的关键人物,此案因此也一度倍受关注。本文将围绕该案
First, the question put forward: In 2005 Zhang Huiqin (a pseudonym) after receiving Shenzhen Fu Wah Medical and Beauty Hospital ”Ogilvy & Mather injection “ Feng Temporal ”surgery, the face painful, although after two surgical abstraction still failed Relieve the pain, so he voted to the State Petitions Bureau and food and Drug Administration at all levels to reflect the situation, but she also accepted the CCTV “Life 3.15 ” section of the interview, “Sohu ” online publication disclosure Ogilvy & Mather “product adverse reactions., Jilin Fuhua company to Zhang Huiqin letters sent to the National Complaints Letter as evidence will be brought to court Zhang Huiqin September 20, Changchun City, South Gate District Court, the case of Jilin Fuhua Company Zhang Huiqin’s reputation right dispute (hereinafter referred to as ”Zhang case“) made the first instance verdict of the defendant losing the case. In the sensational ”Ogilvy & Mather" incident, Zhang Huiqin was considered to be the key figure in promoting the event. Therefore, the case was once also much attention.This article will focus on the case